WATSON 407 (Lisinopril 10 mg)
Pill imprint WATSON 407 has been identified as Lisinopril 10 mg.
Lisinopril is used in the treatment of high blood pressure; migraine prevention; diabetic kidney disease; coronary artery disease; alport syndrome (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 10 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 407
- 10 mg
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
calcium phosphate dihydrate dibasic
FD&C Blue No. 2
|NDC Code||Manufacturer / Repackager|
|63739-0349||McKesson Packaging Services|
Note: Inactive ingredients may vary.
More about lisinopril
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.